However, contrary reports do exist (107–109)—for example, in patients with advanced NSCLC, Guibert et al. found that PD-L1+CTC analysis is highly feasible, and CTCs were more PD-L1-positive than in tissues. The gene discussed is CD274; the disease is non-small cell lung carcinoma.